
Macromolecular drugs are typically injected, but oral dosage forms are being developed to improve the treatment of gastrointestinal conditions such as inflammatory bowel disease.
William Wei Lim Chin is a technical specialist, science and technology, at Catalent Pharma Solutions.

Macromolecular drugs are typically injected, but oral dosage forms are being developed to improve the treatment of gastrointestinal conditions such as inflammatory bowel disease.

Published: July 2nd 2018 | Updated: